Case study download · Healthcare & Life Sciences
Reducing Oracle Fusion Cloud Applications Costs for a Public MedTech Company
A publicly traded medical technology company facing a 19% Oracle Fusion Cloud fee increase engaged Remend to lead its renewal negotiation, cutting an $8.7M three-year quote to $8.0M.
- Published by
- Remend
- Released
- May 2025
- Client
- A publicly traded medical technology company
- Format
- PDF · 1.1 MB
Get your copy
Tell us a little about yourself so we can share similar results with you. Every field is optional — or skip straight to the download.
Prefer to skip the form?Download now